ProductsBack/LEF1 antibody

LEF1 antibody

Name: LEF1 antibody
SKU: GTX129186_G10
Availability: BackOrder

GTX129186

ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Product group Antibodies

TargetLEF1

Overview

Supplier
GeneTex
Product Name
LEF1 antibody
Delivery Days Customer
9
Application Supplier Note
WB: 1:500-1:3000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Applications
Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Certification
Research Use Only
Clonality
Polyclonal
Concentration
1 mg/ml
Conjugate
Unconjugated
Gene ID51176
Target name
LEF1
Target description
lymphoid enhancer binding factor 1
Target synonyms
LEF-1; lymphoid enhancer-binding factor 1; T cell-specific transcription factor 1-alpha; TCF10; TCF1ALPHA; TCF1-alpha; TCF7L3
Host
Rabbit
Isotype
IgG
Protein IDQ9UJU2
Protein Name
Lymphoid enhancer-binding factor 1
Scientific Description
LEF1 is a nuclear protein that is expressed in pre-B and T cells. It binds to a functionally important site in the T-cell receptor-alpha (TCRA; MIM 186880) enhancer and confers maximal enhancer activity. LEF1 belongs to a family of regulatory proteins that share homology with high mobility group protein-1 (HMG1; MIM 163905) (Waterman et al., 1991 [PubMed 2010090]; van Genderen et al., 1994 [PubMed 7958926]).[supplied by OMIM]
Storage Instruction
-20°C or -80°C,2°C to 8°C
UNSPSC
12352203

DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300.
Read more
MiR-378a-3p as a putative biomarker for hepatocellular carcinoma diagnosis and prognosis: Computational screening with experimental validation. Qian F et al., 2021 Feb, Clin Transl Med
Read more
Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human Colorectal Carcinoma Cells Via Suppressing WNT/beta-catenin Signaling. Or CR et al., 2020 Mar 5, Int J Mol Sci
Read more
Lactoferrin promotes hair growth in mice and increases dermal papilla cell proliferation through Erk/Akt and Wnt signaling pathways. Huang HC et al., 2019 Jul, Arch Dermatol Res
Read more
TOP2A induces malignant character of pancreatic cancer through activating beta-catenin signaling pathway. Pei YF et al., 2018 Jan, Biochim Biophys Acta Mol Basis Dis
Read more